These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8618040)

  • 1. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice.
    Ghadially R; Brown BE; Hanley K; Reed JT; Feingold KR; Elias PM
    J Invest Dermatol; 1996 May; 106(5):1064-9. PubMed ID: 8618040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis.
    Harris IR; Farrell AM; Grunfeld C; Holleran WM; Elias PM; Feingold KR
    J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical mevalonic acid stimulates de novo cholesterol synthesis and epidermal permeability barrier homeostasis in aged mice.
    Haratake A; Ikenaga K; Katoh N; Uchiwa H; Hirano S; Yasuno H
    J Invest Dermatol; 2000 Feb; 114(2):247-52. PubMed ID: 10651982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrier function regulates epidermal lipid and DNA synthesis.
    Proksch E; Holleran WM; Menon GK; Elias PM; Feingold KR
    Br J Dermatol; 1993 May; 128(5):473-82. PubMed ID: 8504036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    Menon GK; Feingold KR; Mao-Qiang M; Schaude M; Elias PM
    J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin.
    Zettersten EM; Ghadially R; Feingold KR; Crumrine D; Elias PM
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):403-8. PubMed ID: 9308554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acids are required for epidermal permeability barrier function.
    Mao-Qiang M; Elias PM; Feingold KR
    J Clin Invest; 1993 Aug; 92(2):791-8. PubMed ID: 8102380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model.
    Ghadially R; Brown BE; Sequeira-Martin SM; Feingold KR; Elias PM
    J Clin Invest; 1995 May; 95(5):2281-90. PubMed ID: 7738193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of the epidermal permeability barrier by lipids and hyperproliferation].
    Proksch E
    Hautarzt; 1992 Jun; 43(6):331-8. PubMed ID: 1628964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of de novo cholesterol synthesis in the epidermis influences desquamation of the stratum corneum in aged mice.
    Haratake A; Komiya A; Horikoshi T; Uchiwa H; Watanabe S
    Skin Pharmacol Physiol; 2006; 19(5):275-82. PubMed ID: 16778459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cutaneous permeability barrier disruption on HMG-CoA reductase, LDL receptor, and apolipoprotein E mRNA levels in the epidermis of hairless mice.
    Jackson SM; Wood LC; Lauer S; Taylor JM; Cooper AD; Elias PM; Feingold KR
    J Lipid Res; 1992 Sep; 33(9):1307-14. PubMed ID: 1402399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function.
    Kim M; Jung M; Hong SP; Jeon H; Kim MJ; Cho MY; Lee SH; Man MQ; Elias PM; Choi EH
    Exp Dermatol; 2010 Jun; 19(6):501-10. PubMed ID: 19703225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements.
    Proksch E; Elias PM; Feingold KR
    J Clin Invest; 1990 Mar; 85(3):874-82. PubMed ID: 2312730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization and regulation of epidermal 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by barrier requirements.
    Proksch E; Elias PM; Feingold KR
    Biochim Biophys Acta; 1991 Apr; 1083(1):71-9. PubMed ID: 2031940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis.
    Proksch E; Feingold KR; Elias PM
    J Invest Dermatol; 1992 Aug; 99(2):216-20. PubMed ID: 1629633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements.
    Holleran WM; Gao WN; Feingold KR; Elias PM
    Arch Dermatol Res; 1995; 287(3-4):254-8. PubMed ID: 7598529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.
    Holleran WM; Man MQ; Gao WN; Menon GK; Elias PM; Feingold KR
    J Clin Invest; 1991 Oct; 88(4):1338-45. PubMed ID: 1918384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and biochemical basis for the UVB-induced alterations in epidermal barrier function.
    Holleran WM; Uchida Y; Halkier-Sorensen L; Haratake A; Hara M; Epstein JH; Elias PM
    Photodermatol Photoimmunol Photomed; 1997 Aug; 13(4):117-28. PubMed ID: 9453079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function.
    Behne M; Uchida Y; Seki T; de Montellano PO; Elias PM; Holleran WM
    J Invest Dermatol; 2000 Jan; 114(1):185-92. PubMed ID: 10620136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.